Global Hemostatis and Tissue Sealing Agents Market Report, History and Forecast 2018-2034, Breakdown Data by Manufacturers, Key Regions, Types and Application
Published on: 2024-01-04 | No of Pages : 400 | Industry : Pharma & Healthcare
Publisher : MRA | Format : PDF
Global Hemostatis and Tissue Sealing Agents Market Report, History and Forecast 2018-2034, Breakdown Data by Manufacturers, Key Regions, Types and Application
Hemostasis devices and sealants are used to prevent blood loss in various conditions. Their preference over other wound closure methods had led to its increasing use in multiple conditions, especially in endoscopic procedures. From mild injuries to burns and neurosurgical management,all are catered to by the hemostasis and tissue sealing agents market.
Hemostatis and Tissue Sealing Agents report published by QYResearch reveals that COVID-19 and Russia-Ukraine War impacted the market dually in 2022. Global Hemostatis and Tissue Sealing Agents market is projected to reach US$ 4800.3 million in 2034, increasing from US$ 3178.1 million in 2022, with the CAGR of 6.0% during the period of 2024 to 2034. Demand from Hospitals and Ambulatory Surgical Centers are the major drivers for the industry.
Hemostasis & tissue sealing agents market is expected to gain significant traction over the forecast period owing to rising number of surgeries coupled with increasing number of trauma cases.
Report Scope
This report, based on historical analysis (2018-2022) and forecast calculation (2024-2034), aims to help readers to get a comprehensive understanding of global Hemostatis and Tissue Sealing Agents market with multiple angles, which provides sufficient supports to readers’ strategy and decision making.
Manufacturers, Type, Application and Regions Listed in the Report
Johnson & Johnson
CryoLife Inc.
Advance Medical Solution (AMS) Group Plc.
Cohera Medical Inc.
Integra Life Sciences Corporation
Pfizer Inc.
C R Bard Inc.
Cohesion Technologies Inc
HyperBranch Medical Technology
Biomet Inc.
Medtronic
B Braun Medical Inc.
Smith & Nephew
Segment by Type
Topical Hemostat
Adhesive & Tissue Sealant
Hospitals
Ambulatory Surgical Centers
Home Care Settings
Others
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Indonesia
Thailand
Malaysia
Philippines
Vietnam
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
U.A.E
Each chapter of the report provides detailed information for readers to understand the Hemostatis and Tissue Sealing Agents market further
Chapter 1Product Definition, Product Types, Volume and Revenue analysis of Each Type in North America, Europe, Asia-Pacific, Latin America, Middle East and Africa from 2018 to 2024.
Chapter 2Manufacturer Competition Status, including Sales and Revenue comparison, Manufacturers’ commercial date of Hemostatis and Tissue Sealing Agents, product type offered by each manufacturer, Mergers & Acquisitions activities, Expansion activities occurred in the Hemostatis and Tissue Sealing Agents industry.
Chapter 3Historical (2018-2022) and forecast (2024-2034) volume and revenue analysis of Hemostatis and Tissue Sealing Agents in North America, Europe, Asia-Pacific, Latin America, Middle East and Africa.
Chapter 4Product Application, Volume and Revenue analysis of Each Application in North America, Europe, Asia-Pacific, Latin America, Middle East and Africa from 2018 to 2024.
Chapter 5 to 9Country Level analysis of North America, Europe, Asia-Pacific, Latin America, Middle East and Africa, including volume and revenue analysis.
Chapter 10Manufacturers’ Outline, covering company’s basic information like headquarter, contact information, major business, Hemostatis and Tissue Sealing Agents introduction, etc. Hemostatis and Tissue Sealing Agents Sales, Revenue, Price and Gross Margin of each company as well as Recent Development are also contained in this part.
Chapter 11Industry Chain, like raw materials, manufacturing cost, are covered. In addition, market opportunities and challenges are emphasized as well in the chapter.
Chapter 12Market Channel, Distributors and Customers are listed.
Chapter 13QYResearch’s Conclusions of Hemostatis and Tissue Sealing Agents market based on comprehensive survey.
Chapter 14Methodology and Data Sources adopted by QYResearch.
Hemostatis and Tissue Sealing Agents report published by QYResearch reveals that COVID-19 and Russia-Ukraine War impacted the market dually in 2022. Global Hemostatis and Tissue Sealing Agents market is projected to reach US$ 4800.3 million in 2034, increasing from US$ 3178.1 million in 2022, with the CAGR of 6.0% during the period of 2024 to 2034. Demand from Hospitals and Ambulatory Surgical Centers are the major drivers for the industry.
Hemostasis & tissue sealing agents market is expected to gain significant traction over the forecast period owing to rising number of surgeries coupled with increasing number of trauma cases.
Report Scope
This report, based on historical analysis (2018-2022) and forecast calculation (2024-2034), aims to help readers to get a comprehensive understanding of global Hemostatis and Tissue Sealing Agents market with multiple angles, which provides sufficient supports to readers’ strategy and decision making.
Manufacturers, Type, Application and Regions Listed in the Report
By Company
Johnson & Johnson
CryoLife Inc.
Advance Medical Solution (AMS) Group Plc.
Cohera Medical Inc.
Integra Life Sciences Corporation
Pfizer Inc.
C R Bard Inc.
Cohesion Technologies Inc
HyperBranch Medical Technology
Biomet Inc.
Medtronic
B Braun Medical Inc.
Smith & Nephew
Segment by Type
Topical Hemostat
Adhesive & Tissue Sealant
Segment by Application
Hospitals
Ambulatory Surgical Centers
Home Care Settings
Others
Segment by Region
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Indonesia
Thailand
Malaysia
Philippines
Vietnam
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
U.A.E
Each chapter of the report provides detailed information for readers to understand the Hemostatis and Tissue Sealing Agents market further
Chapter 1Product Definition, Product Types, Volume and Revenue analysis of Each Type in North America, Europe, Asia-Pacific, Latin America, Middle East and Africa from 2018 to 2024.
Chapter 2Manufacturer Competition Status, including Sales and Revenue comparison, Manufacturers’ commercial date of Hemostatis and Tissue Sealing Agents, product type offered by each manufacturer, Mergers & Acquisitions activities, Expansion activities occurred in the Hemostatis and Tissue Sealing Agents industry.
Chapter 3Historical (2018-2022) and forecast (2024-2034) volume and revenue analysis of Hemostatis and Tissue Sealing Agents in North America, Europe, Asia-Pacific, Latin America, Middle East and Africa.
Chapter 4Product Application, Volume and Revenue analysis of Each Application in North America, Europe, Asia-Pacific, Latin America, Middle East and Africa from 2018 to 2024.
Chapter 5 to 9Country Level analysis of North America, Europe, Asia-Pacific, Latin America, Middle East and Africa, including volume and revenue analysis.
Chapter 10Manufacturers’ Outline, covering company’s basic information like headquarter, contact information, major business, Hemostatis and Tissue Sealing Agents introduction, etc. Hemostatis and Tissue Sealing Agents Sales, Revenue, Price and Gross Margin of each company as well as Recent Development are also contained in this part.
Chapter 11Industry Chain, like raw materials, manufacturing cost, are covered. In addition, market opportunities and challenges are emphasized as well in the chapter.
Chapter 12Market Channel, Distributors and Customers are listed.
Chapter 13QYResearch’s Conclusions of Hemostatis and Tissue Sealing Agents market based on comprehensive survey.
Chapter 14Methodology and Data Sources adopted by QYResearch.
Electronic and Semiconductor
Food and Beverages
Chemicals and Materials
Consumer Goods
Construction Manufacturing
Aerospace and Defence
Energy and Power
ICT Media
Banking and Finance
Automotive and Transportation
Machinery and Equipments
Pharmaceutical and Healthcare
Medical Devices